OptimizeRx Corp.

OPRX Healthcare Health Information Services

OptimizeRx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $109.4 million, up 18.8% from fiscal 2024. In the quarter to June 2026, revenue fell 29.8%, EPS fell 150.0%, free cash flow grew 89.9% and total debt fell 33.1%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

8.50 0.35 −3.95%
Market cap
$166.7M
P/E
35.4×
Fwd P/E
23.0×
Dividend yield
—
F-score
8/9
Altman Z
3.31
Beneish M
−2.77
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
23.37 13.38 13.85 74.14 84.68 10.52 18.85 8.91 5.12 7.03
Receivables
38.50 38.21 37.29 22.16 24.80 17.89 7.42 6.46 3.43 3.06
Total current assets
64.72 53.97 54.33 98.58 115.11 32.86 27.14 15.73 8.81 10.18
Property, Plant, Equpment (Net)
0.11 0.15 0.15 0.14 0.14 0.15 0.18 0.15 0.17 0.17
Software (Capitalized)
— — — — — — — — — 0.35
Goodwill and Intangible Assets (Total)
111.67 116.39 127.75 35.70 25.39 26.86 28.68 8.94 0.78 0.77
Long-term assets (Other)
0.03 0.30 0.57 0.01 0.01 0.01 0.08 0.24 0.01 0.01
Total non-current assets
112.20 117.20 129.04 36.07 25.87 27.47 29.50 9.32 0.95 1.30
Total Assets
176.92 171.17 183.37 134.65 140.99 60.33 56.64 25.05 9.76 11.48
Accounts Payable
1.64 2.16 2.23 1.55 0.61 0.62 0.49 0.41 0.46 0.37
Accrued Expenses
11.59 8.49 7.71 2.60 2.90 2.42 1.80 1.30 0.95 0.29
Current Part of Debt
4.26 2.00 2.00 0.09 0.09 0.12 0.12 — — —
Current Part of Taxes to Pay
0.00 0.32 0.05 — — — — — — —
Current Revenue (Deferred)
0.50 0.47 0.17 0.16 1.39 0.29 0.58 0.61 0.51 0.39
Other current liabilities
— — — — — 1.61 1.50 3.82 3.09 3.30
Total current liabilities
21.26 18.65 17.88 8.40 9.37 10.03 6.11 4.23 3.54 3.67
Long Term Debt (Total)
21.42 30.82 34.23 0.14 0.24 0.33 0.45 — — —
Long Term Tax Liability (Deferred)
5.71 4.49 4.34 — — — — — — —
Non-current Liabilities (Other)
— — — — — — 5.22 2.37 — —
Total non-current liabilities
27.36 35.52 38.94 0.14 0.24 0.33 5.67 2.37 — —
Total liabilities
48.62 54.17 56.82 8.54 9.61 10.35 11.78 6.60 3.54 3.67
Additional Paid In Capital
207.51 201.35 190.79 172.79 166.62 85.59 78.27 48.73 35.29 33.75
Common Stock (Net)
0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.03
Retained Earnings
(79.24) (84.37) (64.26) (46.69) (35.25) (35.63) (33.42) (30.28) (30.36) (28.26)
Equity Equivalent
— — — — — — — — 1.29 2.29
Treasury Stock
0.00 0.00 0.00 0.00 — — — — — —
Common Equity (Total)
128.29 117.00 126.55 126.11 131.38 49.97 44.86 18.46 6.22 7.81
Shareholders Equity (Total)
128.29 117.00 126.55 126.11 131.38 49.97 44.86 18.46 6.22 7.81
Shareholders Equity and Liabilities (Total)
176.92 171.17 183.37 134.65 140.99 60.33 56.64 25.05 9.76 11.48
Shares (Common)
18.76 18.45 18.16 17.07 17.86 15.22 14.61 12.04 9.77 9.91
Shareholders Equity (Tangible)
16.63 0.61 (1.20) 90.41 105.99 23.11 16.18 9.52 5.44 7.04
Net Debt
2.31 19.44 22.38 (73.91) (84.35) (10.07) (18.29) (8.91) (5.12) (7.03)
Total Debt
25.68 32.82 36.23 0.23 0.33 0.45 0.56 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates